Safety of corticosteroid therapy in sarcoidosis treatment
Introduction: Sarcoidosis is a multisystemic granulomatous disease of unknown origin and unpredictable cause, characterized by a dysregulated immune response. If histopathological hallmark is represented by the presence of non-caseating granulomas, clinical manifestations are variable and symptoms a...
Saved in:
Main Authors: | Alessandro Di Marco Berardino (Author), Federico Mei (Author), Lina Zuccatosta (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treatment of angiolupoid sarcoidosis with tofacitinib ointment 2% and pulsed dye laser therapy
by: Katelyn Singh, BS, et al.
Published: (2021) -
Sarcoidosis
Published: (2013) -
Ruxolitinib cream for the treatment of cutaneous sarcoidosis
by: Jeffrey S. Smith, MD, PhD, et al.
Published: (2023) -
Topical Pimecrolimus as a New Optional Treatment in Cutaneous Sarcoidosis of Lichenoid Type
by: Antonella Tammaro, et al.
Published: (2014) -
Treatment of cutaneous sarcoidosis with tofacitinib: A case report and review of evidence for Janus kinase inhibition in sarcoidosis
by: Ronan Talty, BS, et al.
Published: (2021)